Successful management of post-COVID-19 acanthamoebic encephalitis.
Int J Infect Dis
; 110: 226-228, 2021 Sep.
Article
in English
| MEDLINE | ID: covidwho-1322131
ABSTRACT
Acanthamoebic encephalitis is a rare and highly fatal disease that has no standard management protocol. Coronavirus disease 2019 (COVID-19) causes immune dysfunction and may predispose patients to this infection. The present study describes successful management of acanthamoebic encephalitis in a young male who recently recovered from COVID-19 using a combination of medical and surgical approaches. A combination of miltefosine with other agents with trophicidal and cysticidal activities should be used in the regimen. Surgical excision of the abscess should be undertaken whenever feasible.
Keywords
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
Encephalitis
/
COVID-19
Type of study:
Case report
Topics:
Long Covid
Limits:
Humans
/
Male
Language:
English
Journal:
Int J Infect Dis
Journal subject:
Communicable Diseases
Year:
2021
Document Type:
Article
Affiliation country:
J.ijid.2021.07.046
Similar
MEDLINE
...
LILACS
LIS